The intensive production and transportation of shrimp from hatchery to nursery and rearing ponds can provide ideal environments in which highly contagious shrimp disease-causing organisms can flourish. Pathogens such as Early Mortality Syndrome (EMS), Luminescent Disease and White Spot Syndrome (WSSv) can rapidly spread throughout entire shrimp farm populations, resulting in poor growth, high mortality rates and potentially serve revenue losses.

Specialty chemicals company, LANXESS, offers shrimp producers two unique disinfectant formulations, Virkon™ DTOX and Virkon™ AQUATIC, both scientifically developed to address and meet the viral, bacterial and fungal pathogen control needs of a modern, intensified shrimp production.

Virkon™ – the science to kill pathogens

Virkon™ DTOX has been specifically developed to address disease challenges that can occur during post-larvae (PL) transportation.  It can be applied directly into water reservoir tanks and shrimp PL transportation bags to help control pathogen pressure, whilst having no toxicological effect on the shrimp PL themselves.

Virkon™ AQUATIC is a synergistic and balanced mix of ingredients scientifically formulated to achieve rapid maximum pathogen killing power while having no negative toxicological effect on the ecosystem of the rearing pond or shrimp themselves.

With proven efficacy against the most important viruses and bacteria that threaten modern shrimp production today, Virkon™ AQAUTIC has been proven to rapidly knock-down and control pathogen pressure, reduce the rate of infection spread within shrimp populations and reduce the risk of diseases spreading to adjacent ponds.

“When a shrimp farmer is faced with a highly contagious disease which rapidly spreads throughout and kills shrimp farm populations, at any stage of the production cycle, their entire investment can be lost”. Grin Swangdacharuk, APAC Aquaculture Technical Marketing Manager in the Material Protection Products business unit (MPP) at LANXESS, explains. “It is therefore essential to prevent, contain and control the spread of disease-causing pathogens as effectively and quickly as possible via implementation of biosecurity best practice protocols and the use of disinfectants with proven broad spectrum efficacy against shrimp disease-causing pathogens” adds Swangdacharuk.

Visit LANXESS at Asia Pacific Aquaculture (APA) 2019, Chennai Central Trade, Chennai, Tamil Nadu, India, stand 60-63, June 19-21, 2019 for further information and advice.

Read more about LANXESS and their commitment to biosecurity at


LANXESS is a leading specialty chemicals company with sales of EUR 7.2 billion in 2018. The company currently has about 15,500 employees in 33 countries and is represented at 60 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Forward-Looking Statements

This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person’s officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.